Literature DB >> 23696625

Implantation of cardioverter defibrillators with minimal fluoroscopy using a three-dimensional navigation system: a feasibility study.

Sergio Castrejón-Castrejón1, Armando Pérez-Silva, Elkin González-Villegas, Omar Al-Razzo, Jorge Silvestre, David Doiny, Alejandro Estrada-Mucci, David Filgueiras-Rama, Marta Ortega-Molina, José Luis López-Sendón, José Luis Merino.   

Abstract

AIMS: Fluoroscopy is necessary to implant cardioverter defibrillators using the conventional approach. Modern electroanatomic navigation systems allow the visualization of multiple catheters and, as they are capable of rendering precise geometrical reconstructions of cardiac chambers, have been used for fluoroscopy-free electrophysiological procedures. The aim of our study was to assess the feasibility of non-fluoroscopic implants using a three-dimensional navigation system. METHODS AND
RESULTS: The NavX system was used to create the virtual anatomies of heart chambers and thoracic veins. Defibrillator leads were placed at stable positions using exclusively the electrical and anatomical information provided by the navigator. A single fluoroscopy shot confirmed final lead positions. Thirty-five consecutive patients had 30 single-chamber and 5 dual-chamber defibrillators implanted. Cardiac chambers geometries were developed in 10 ± 4.3 min. Ventricular and atrial leads were implanted, with suitable positions and electrical parameters being achieved, in 18 ± 22 and 16 ± 9 min, respectively. The final confirmatory shot was the only fluoroscopy needed in 31 (89%) cases. Two patients needed fluoroscopy-guided relocation of the ventricular lead due to high defibrillation threshold and a breakdown of the active-fixation mechanism, respectively. In one patient the ventricular lead was totally extracted and reimplanted because a loop has formed in the vena cava, and one patient required fluoroscopy-guided subclavian puncture. In five cases (16%), the position of the proximal defibrillation coil was minimally modified with fluoroscopy due to incomplete geometric reconstruction of the superior vena cava.
CONCLUSION: Fluoroscopy-free defibrillators implantation is feasible using a navigation system. Suitable placement of the proximal coil is a critical stage and requires a reliable and complete reconstruction of the superior vena cava.

Entities:  

Keywords:  Defibrillation lead; Electroanatomic navigation system; Fluoroscopy; Implantable cardioverter defibrillator; Implantation procedure; Minimum fluoroscopy; Radiation

Mesh:

Year:  2013        PMID: 23696625     DOI: 10.1093/europace/eut127

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

Review 1.  Pregnancy in patients with implantable cardiac defibrillators.

Authors:  Geoffrey R Wong; Megan Ang; Jasveer Jayarajan; Fiona Walker; Pier D Lambiase
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-05-10

Review 2.  Three-dimensional mapping in cardiac implantable electronic device - a feasible and effective alternative to fluoroscopy.

Authors:  Xiaozhen Ge; Mengna Chen; Zhongxin Sha; Junmeng Zhang
Journal:  J Interv Card Electrophysiol       Date:  2022-07-09       Impact factor: 1.900

3.  Transvenous nonfluoroscopic pacemaker implantation during pregnancy guided by 3-dimensional electroanatomic mapping.

Authors:  Jacob Hartz; Bradley C Clark; Seiji Ito; Elizabeth D Sherwin; Charles I Berul
Journal:  HeartRhythm Case Rep       Date:  2017-08-10

4.  Electroanatomical mapping- and CT scan image integration-guided pacing lead implantation: A case series and review of the recent literature.

Authors:  Jens Kristensen; Mads Brix Kronborg; Christian Gerdes; Jens Cosedis Nielsen
Journal:  Heart Rhythm O2       Date:  2020-10-28

5.  Implantation of single lead cardioverter defibrillator with floating atrial sensing dipole in a pregnant patient without using fluoroscopy.

Authors:  Fabio Quartieri; Daniele Giacopelli; Matteo Iori; Nicola Bottoni
Journal:  Indian Pacing Electrophysiol J       Date:  2016-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.